0%
Products > TruDiagnosis® > TruArray BER Assay
Many bacteria have an impact on the nature, extent, and fate of environmental contaminants, either through direct or indirect biological activity. Current methods for monitoring microbial community dynamics either do not provide the necessary breadth of coverage for important functional groups, or they are too expensive and slow to provide real-time, actionable information for site engineers or regulators charged with site reclamation, stewardship or closure.
TruArray BER assay is the first molecular field-portable microbial surveillance and indicator technology for same-day testing and monitoring of environmental samples undergoing in situ bioremediation. The assay detects 35 of the most common bacterial genera associated with in situ remediation of heavy metals, radionuclides, organics, chlorinated solvents and DNAPLs in a single assay, from a single sample. Functional groups include metal-, sulfate- and nitrate-reducers, dechlorinators, and fermenters.
Chandler DP, Kukhtin A, Mokhiber R, Knickerbocker C, Ogles D, Rudy G, Golova J, Long P, Peacock A. 2010. Monitoring microbial community structure and dynamics during in situ U(VI) bioremediation with a field-portable microarray analysis system. Env. Sci. Technol. 44: 5516-5522.
Eyers L, Smoot JC, Smoot LM, Bugli C, Urakawa H, McMurry Z, Siripong S, El-Fantroussi S, Lambert P, Agathos SN, Stahl DA. 2006. Discrimination of shifts in a soil microbial community associated with TNT-contamination using a functional ANOVA of 16S rRNA hybridized to oligonucleotide microarrays. Environ Sci Technol. 40(19): 5867-73.
Siripong S, Kelly JJ, Stahl DA, Rittmann BE. 2006. Impact of prehybridization PCR amplification on microarray detection of nitrifying bacteria in wastewater treatment plant samples. Environ Microbiol. 8(9): 1564-74.
* All of Akonni Biosystems tests are currently for Research Use Only, and are not for use in diagnostic procedures. Akonni is interacting with the Food & Drug Administration (FDA) in order to develop and prepare pre-market notifications seeking clearance to market these products as diagnostic assays in the U.S.
Based on its recent analysis of the microarrays in molecular diagnostics (MDx) market, Frost & Sullivan recognizes Akonni Biosystems with the 2017 North American New Product Innovation Award.
Akonni’s integrated MDx system, TruDiagnosis®, is revolutionizing the point-of-care molecular testing market by enabling target detection from a variety of sample types. TruDiagnosis® is powered by TruArray®, a patented 3D gel-drop microarray technology for sample screening that instantly indicates the presence of disease markers in real time.
Download:
